Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

233279 Coagulation Factor IX, Human Plasma

233279
Purchase on Sigma-Aldrich

Overview

Replacement Information

Products

Catalogue NumberPackaging Qty/Pack
233279-100U Plastic ampoule 100 u
Description
OverviewNative coagulation factor IX from human plasma. Sold on the basis of plasma equivalent units. 100 plasma equivalent units are equal to 500 µg of Factor IX. In vivo, activation of Factor IX to IXa occurs via either the tissue factor/Factor VIIa complex (the extrinsic pathway), or Factor XIa (the intrinsic pathway). Activated Factor IXa, in a complex with Factor VIIIa, can then convert Factor X to Xa, the catalytic component of the prothrombinase complex.
Catalogue Number233279
Brand Family Calbiochem®
SynonymsAntihemophilic Factor B, Christmas Factor, Plasma Thromboplastin Component, PTC
References
Product Information
CAS number9001-28-9
FormLiquid
FormulationIn 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5.
Quality LevelMQ200
Applications
Biological Information
Purity≥95% by SDS-PAGE
SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Specific Activity≥150 units/mg protein (clotting assay). Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSEC6045000
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Standard Handling
Storage ≤ -70°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

Coagulation Factor IX, Human Plasma SDS

Title

Safety Data Sheet (SDS) 

Coagulation Factor IX, Human Plasma Certificates of Analysis

TitleLot Number
233279
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision02-January-2008 JSW
SynonymsAntihemophilic Factor B, Christmas Factor, Plasma Thromboplastin Component, PTC
DescriptionNative coagulation factor IX from human plasma. Sold on the basis of plasma equivalent units. 100 plasma equivalent units are equal to 500 µg of Factor IX. In vivo, activation of Factor IX to IXa occurs via either the tissue factor/Factor VIIa complex (the extrinsic pathway), or Factor XIa (the intrinsic pathway). Activated Factor IXa, in a complex with Factor VIIa, can then convert Factor X to Xa, the catalytic component of the prothrombinase complex.
FormLiquid
FormulationIn 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5.
Concentration Label Please refer to vial label for lot-specific concentration
SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
CAS number9001-28-9
RTECSEC6045000
Purity≥95% by SDS-PAGE
Specific activity≥150 units/mg protein (clotting assay). Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma
Storage ≤ -70°C
Avoid freeze/thaw
Do Not Freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
Toxicity Standard Handling
Merck USA index14, 3922